FedInvent™ Patent Applications

New Taxpayer Funded Applications for Thursday, March 24, 2022 

This page was updated on Saturday, March 26, 2022 at 04:19 PM GMT

FedInvent analyzed 197 taxpayer funded patent applications this week.

On March 24, 2022, the US Patent Office published 8,431 pre-grant patent applications, 197 benefitted from taxpayer funding. Here is how things broke down on Thursday.

  • One hundred eighty-eight (188) patent applications have Government Interest Statements.
  • Twenty-six (26) applications have an applicant or an assignee that is a government agency.
  • A federal department is the only assignee on 16 patent applications.
  • The 197 new patent applications have 231 department-level funding citations. 
  • These applications are the work of 673 inventors.
  • The 637 American inventors come from 37 states and the District of Columbia.
  • The 36 foreign inventors come from 13 countries.
  • This week there are four (4) foreign inventors from China.
  • There are 140 patent applications (71%) where at least one assignee is a college or university, the HERD.
  • Nineteen (19) patent applications resulted from the collaboration between two or more universities.
  • Federally Funded Research and Development Centers (FFRDCs) have ten (10) published patent applications.
  • There is one patent applications with a Y CPC symbol indicating that the invention may be useful in mitigating the impact of climate change.

The Big Three

California got knocked out of its number one position this week. This week's top three states are:

  1. Massachusetts had 32 first-named inventors and 111 total inventors.
  2. California had 28 first-named inventors and 90 total inventors.
  3. Maryland had 13 first-named inventors and 46 total inventors.

The inventors from the top three states account for 39% of the inventors on the week's published patent applications.

Learn More About Taxpayer Funded Patents Here

The List of This Week's Patent Applications

Just a list — patent application publication number with a link and the title, for those patentistas who like to browse.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent you are interested appears at the top of the list on the details page.
Patent Application Title
001 20220087285
 
DIETARY EARLY GLYCATION PRODUCTS FOR TREATING AND PREVENTING AUTOIMMUNE DISEASES 
002 20220087565
 
SMART ELASTIC FABRIC TAPE FOR DISTRIBUTED SKIN STRAIN, MOVEMENT, AND MUSCLE ENGAGEMENT MONITORING 
003 20220087595
 
METHOD FOR CHARACTERIZATION OF THE FEMALE PELVIC FLOOR WITH A BIOMECHANICAL INTEGRITY SCORE 
004 20220087607
 
PHYSIOLOGICAL SENSING TEXTILE APPARATUS 
005 20220087651
 
Systems and Methods for Microvessel Ultrasound Imaging 
006 20220087813
 
ANTI-PULFRICH MONOVISION OPHTHALMIC CORRECTION 
007 20220087817
 
Prosthetic Heart Valve with Tri-Leaflet Design for Use in Percutaneous Valve Replacement Procedures 
008 20220087860
 
METHOD AND SYSTEM FOR REGULATING CORE BODY TEMPERATURE 
009 20220087930
 
SARS-CoV-2 Subunit Vaccine and Microneedle Array Delivery System 
010 20220087950
 
COMPOUNDS, TARGETS AND PATHWAYS FOR MACROPHAGE MODULATION 
011 20220087954
 
USE OF 2-HYDROXYBENZYLAMINE FOR THE TREATMENT OF SYSTEMIC LUPUS 
012 20220087970
 
PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION 
013 20220087977
 
METHODS FOR THE PREVENTION OR TREATMENT OF CYTOKINE STORM 
014 20220087992
 
COMPOUNDS AND METHODS OF TREATING RETINAL DEGENERATION 
015 20220088010
 
Co-Administration of inhibitors to produce insulin producing gut cells 
016 20220088019
 
PAC-1 COMBINATION THERAPY 
017 20220088026
 
METHODS OF TREATING TYROSINE KINASE INHIBITOR-INDUCED DIARRHEA 
018 20220088028
 
NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR PARTIAL AGONISTS AS THERAPEUTICS FOR CHRONIC TINNITUS 
019 20220088031
 
METHODS AND COMPOSITIONS FOR TREATING RESISTANT AND RECURRENT FORMS OF CANCER 
020 20220088053
 
Usb1 Directed Regulation Of Mirnas Related Hematopoietic Differentiation And Affected In Multiple Forms Of Leukemia 
021 20220088058
 
ANTISENSE OLIGOMERS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION-5 AND DRAVET SYNDROME 
022 20220088065
 
Inorganic Nitrite to Improve Cardiopulmonary Hemodynamics 
023 20220088092
 
COMPOSITIONS AND METHODS FOR INCREASING THE VIABILITY OF FREEZE-DRIED PROBIOTICS 
024 20220088117
 
SERINE PROTEINASE INHIBITORS: SERP-1 AND SERP-1 RCL-DERIVED PEPTIDES EFFECT ON MICROBIOME COMPOSITION AND USES THEREOF 
025 20220088119
 
THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE 
026 20220088127
 
TARGETING THE BAG FAMILY FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE 
027 20220088133
 
Nanoliposome Compositions And Methods Of Treating Stroke 
028 20220088145
 
IMMUNOTHERAPY FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY BOWEL DISEASE 
029 20220088152
 
COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATPASE-MEDIATED DISEASES 
030 20220088163
 
HYBRID IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY 
031 20220088164
 
ANTI-MUTATED KRAS T CELL RECEPTORS 
032 20220088170
 
METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION 
033 20220088171
 
IMMUNOGENIC COMPOSITIONS AND USES THEREOF 
034 20220088173
 
FOOT-AND-MOUTH DISEASE VACCINE 
035 20220088174
 
GENOMIC VARIANTS IN IG GENE REGIONS AND USES OF SAME 
036 20220088180
 
IMMUNOGENIC COMPOSITIONS AND USE THEREOF 
037 20220088183
 
CHIMERIC ONCOLYTIC HERPESVIRUS THAT STIMULATES AN ANTITUMOR IMMUNE RESPONSE 
038 20220088185
 
PASSIVE TRANSFER OF IMMUNITY USING RECOMBINANT HERPES SIMPLEX VIRUS 2 (HSV-2) VACCINE VECTORS 
039 20220088204
 
ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME 
040 20220088208
 
PHLIP®-MEDIATED INTRACELLULAR DELIVERY OF IMMUNO-STIMULATORY COMPOUNDS 
041 20220088211
 
O-LINKED GLYCOSYLATION RECOGNITION MOTIFS 
042 20220088215
 
METHODS OF MAKING TARGETED VESICLES, AND COMPOSITIONS MADE THEREBY 
043 20220088216
 
VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS 
044 20220088222
 
COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES 
045 20220088226
 
PYRIMIDINE NUCLEOSIDE COMPOUNDS FOR FLUORESCENCE IMAGING AND SPECTROSCOPY 
046 20220088228
 
ROD-SHAPED PLANT VIRUS NANOPARTICLES AS IMAGING AGENT PLATFORMS 
047 20220088229
 
PSMA-BINDING AGENTS AND USES THEREOF 
048 20220088268
 
PARTICULATE COATED HYDROGEL MICROPARTICLES 
049 20220088274
 
Targeted in Situ Therapeutic Delivery of Secreted Factors from Stem Cells for Treatment of Damaged Tissue 
050 20220088304
 
SYSTEMS AND METHODS FOR CLOSED-LOOP CONTROL OF INSULIN-GLUCOSE DYNAMICS 
051 20220088417
 
METHOD FOR OPTIMIZING RADIATION BEAM INTENSITY PROFILE SHAPE USING DUAL MULTIPLE APERTURE DEVICES 
052 20220088555
 
SELF-STABILIZED THERMOTHICKENING COLLOIDS 
053 20220088556
 
Aqueous Systems Of At Least Two Phases Containing Microcapsules And Processes For Manufacturing The Same 
054 20220088588
 
MULTI-DIMENSIONAL DOUBLE SPIRAL DEVICE AND METHODS OF USE THEREOF 
055 20220088601
 
Method and System for Sample Collection, Storage, Preparation and Detection 
056 20220088846
 
MULTILAYERED STRUCTURES AND USES THEREOF IN SECURITY MARKINGS 
057 20220088868
 
SYSTEM AND METHOD FOR ROLL-TO-ROLL FILM TENSIONING FOR REDUCED SEPARATION FORCE DURING BOTTOM-UP STEREOLITHOGRAPHY 
058 20220088876
 
ADDITIVE MANUFACTURING SYSTEM WITH AT LEAST ONE ELECTRONIC NOSE 
059 20220088881
 
SYSTEM AND METHOD FOR SIMULATION-ASSISTED ADDITIVE MANUFACTURING 
060 20220089381
 
SYSTEM FOR TRANSFERRING ARTICLES FROM A CONTAINER 
061 20220089445
 
PRODUCTION OF CARBON NANOCHAINS AND NANOTUBES FROM BIOMASS 
062 20220089483
 
SYSTEMS AND METHODS FOR MOISTURE CONDITIONING AGGREGATE WITH AN ALKALINE COMPOUND 
063 20220089487
 
OIL-TREATED PLASTIC FOR CONCRETE 
064 20220089496
 
HIERARCHICAL ORGANIC-INORGANIC COMPOSITES SYNTHESIZED BY ELECTROSPINNING FIBERS WITHIN A NON-CONDUCTIVE AND A CONDUCTIVE PRE-CERAMIC GEL 
065 20220089508
 
Non-Cryogenic, Ammonia-Free Reduction of Aryl Compounds 
066 20220089537
 
HIGH-THROUGHPUT METHOD TO RAPIDLY ADD CHEMICAL MOIETIES TO A SMALL MOLECULE LIBRARY 
067 20220089549
 
INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF 
068 20220089565
 
MODULATORS OF P97 AAA ATPASE ACTIVITY 
069 20220089576
 
ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS 
070 20220089577
 
KU INHIBITORS AND THEIR USE 
071 20220089579
 
BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS 
072 20220089581
 
INHIBITORS OF SPINSTER HOMOLOG 2 (SPNS2) FOR USE IN THERAPY 
073 20220089602
 
COMPOUNDS THAT INDUCE FERROPTIC CELL DEATH 
074 20220089611
 
INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF 
075 20220089616
 
CARBORANE-BASED HISTONE DEACETYLASE (HDAC) INHIBITORS 
076 20220089638
 
DITHIOCARBAMATE STAPLED PEPTIDES AND METHODS OF MAKING AND USE THEREOF 
077 20220089644
 
C1q AND HMGB1 FUSION PROTEINS AND USES THEREOF 
078 20220089651
 
METHODS AND COMPOSITIONS FOR ANTIBODY-EVADING VIRUS VECTORS 
079 20220089654
 
MUTANT TRANSPORTERS FOR BACTERIAL UPTAKE OF TEREPHTHALIC ACID 
080 20220089660
 
IDENTIFICATION OF MUTATIONS IN CHANNELOPSIN VARIANTS HAVING IMPROVED LIGHT SENSITIVITY AND METHODS OF USE THEREOF 
081 20220089665
 
Peptide Compounds and Methods of Use in Wound Healing 
082 20220089670
 
Gene Therapy for BEST1 Dominant Mutations 
083 20220089673
 
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION 
084 20220089677
 
ANTI-KRAS-G12D T CELL RECEPTORS 
085 20220089694
 
EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF 
086 20220089696
 
ARENAVIRUS MONOCLONAL ANTIBODIES AND USES 
087 20220089717
 
MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4) 
088 20220089752
 
COMPOSITIONS AND METHODS FOR MODULATING CELLULAR INTERNALIZATION 
089 20220089777
 
NOVEL HUMANIZED ANTIBODIES AGAINST FACTOR XI HAVING ANTI-THROMBOTIC AND ANTI-INFLAMMATORY EFFECT AND USES THEREOF 
090 20220089784
 
Antibodies for Botulinum Neurotoxins 
091 20220089817
 
POLYAMIDE COMPOSITIONS AND ARTICLES INCORPORATING THE SAME 
092 20220089821
 
HYDROGEL-ENCAPSULATED BETA CELLS, BETA-CELL ENCAPSULATION PROCESS, AND USES THEREOF 
093 20220089989
 
DEVICES FOR SIMULATING A FUNCTION OF A TISSUE AND METHODS OF USE AND MANUFACTURING THEREOF 
094 20220090000
 
APPARATUS AND PROCESSES FOR ISOLATING BIOLOGICAL MATERIAL 
095 20220090009
 
HUMAN PLURIPOTENT STEM CELL-BASED SYSTEM FOR GENERATING ENDOTHELIAL CELLS 
096 20220090021
 
IN VITRO HUMAN BLOOD BRAIN BARRIER 
097 20220090026
 
VIRAL NANOPARTICLE MULTIMERS 
098 20220090027
 
ENGINEERED POLYPEPTIDES THAT EXHIBIT INCREASED CATALYTIC EFFICIENCY FOR UNNATURAL COFACTORS AND USES THEREOF 
099 20220090055
 
MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO CARBOHYDRATE-BINDING MONOCLONAL ANTIBODY FAMILY PGT128 
100 20220090070
 
METHODS AND COMPOSITIONS FOR ALTERING FUNCTION AND STRUCTURE OF CHROMATIN LOOPS AND/OR DOMAINS 
101 20220090071
 
SPINAL MUSCULAR ATROPHY (SMA) TREATMENT VIA TARGETING OF SMN2 SPLICE SITE INHIBITORY SEQUENCES 
102 20220090076
 
5-HALOURACIL-MODIFIED MICRORNAS AND THEIR USE IN THE TREATMENT OF CANCER 
103 20220090079
 
Methods and Compositions for Managing Vascular Conditions Using miR-483 Mimics and HIF1alpha Pathway Inhibitors 
104 20220090083
 
TARGETING EGLN1 IN CANCER 
105 20220090086
 
IDENTIFICATION OF MOLECULAR PATHWAYS AND METHODS OF USE THEREOF FOR TREATING RETINAL NEURODEGENERATION AND OTHER NEURODEGENERATIVE DISORDERS 
106 20220090089
 
ENGINEERED MULTI-OMIC DISPLAY CONSTRUCTS AND DISPLAY SYSTEMS 
107 20220090092
 
ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN EXPRESSION 
108 20220090097
 
REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY 
109 20220090136
 
SIN NOMBRE VIRUS FULL-LENGTH M SEGMENT-BASED DNA VACCINES 
110 20220090137
 
METHODS AND COMPOSITIONS FOR CIRCULAR RNA MOLECULES 
111 20220090139
 
DESIGN OF BACTERIOPHAGE-BASED ARTIFICIAL VIRUSES FOR HUMAN GENOME REMODELING 
112 20220090145
 
RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci 
113 20220090146
 
ATTB CELL LINE, TRANSGENIC CELL LINES DERIVED THEREFROM, AND METHODS OF MAKING THE SAME 
114 20220090163
 
FRACTIONAL INITIATOR HYBRIDIZATION CHAIN REACTION 
115 20220090164
 
METHODS FOR THE DETECTION OF DNA-RNA PROXIMITY IN VIVO 
116 20220090167
 
ASYMMETRIC NANOPORE MEMBRANE (ANM) FILTRATION FOR HIGH-EFFICIENCY VIRUS ENRICHMENT AND PURIFICATION 
117 20220090176
 
Methods of Epigenetic Analysis 
118 20220090178
 
DEVICES FOR CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS 
119 20220090200
 
DNA METHYLATION MEASUREMENT FOR MAMMALS BASED ON CONSERVED LOCI 
120 20220090201
 
CLINICAL ASSESSMENT OF CEREBRAL VASOSPASM RISK FOLLOWING ANEURYSMAL SUBARACHNOID HEMORRHAGE 
121 20220090203
 
NON-INVASIVE BLOOD BASED MONITORING OF GENOMIC ALTERATIONS IN CANCER 
122 20220090206
 
COLORECTAL CANCER RECURRENCE GENE EXPRESSION SIGNATURE 
123 20220090300
 
FOCUSED ROTARY JET SPINNING DEVICES AND METHODS OF USE THEREOF 
124 20220090505
 
AIRFOIL HAVING CAVITY INSERT TO SEPARATE FLOW 
125 20220090587
 
PROPELLANT APPARATUS 
126 20220090788
 
TRAPPED VORTEX COMBUSTOR FOR A GAS TURBINE ENGINE WITH A DRIVER AIRFLOW CHANNEL 
127 20220090811
 
DETECTING PRESENCE AND ESTIMATING THERMAL COMFORT OF ONE OR MORE HUMAN OCCUPANTS IN A BUILT SPACE IN REAL-TIME USING ONE OR MORE THERMOGRAPHIC CAMERAS AND ONE OR MORE RGB-D SENSORS 
128 20220090882
 
DEPLOYABLE ORIGAMI-INSPIRED BARRIERS 
129 20220090917
 
THREE DIMENSIONAL MICROSTRUCTURES WITH SELECTIVELY REMOVED REGIONS FOR USE IN GYROSCOPES AND OTHER DEVICES 
130 20220091014
 
METHOD AND SYSTEM FOR IMPEDANCE-BASED QUANTIFICATION AND MICROFLUIDIC CONTROL 
131 20220091019
 
CONTACT-FREE HOLOGRAPHIC IMAGING OF AEROSOL PARTICLES FROM MOBILE PLATFORMS 
132 20220091032
 
Two-Dimensional Second Harmonic Dispersion Interferometer 
133 20220091040
 
BIOLOGICAL SENSING AND COMMUNICATION USING OPTOGENETICS AND ELECTRONICS 
134 20220091044
 
OPTICAL CAVITY SURFACE BIOCONJUNCTION USING LIPID MEMBRANES FOR LABEL FREE, ULTRASENSITIVE DETECTION OF BIOMOLECULES 
135 20220091064
 
SILVER-SILVER SULFIDE REFERENCE ELECTRODE 
136 20220091071
 
METHODS AND SYSTEMS FOR EVALUATING A TARGET USING PULSED, ENERGETIC PARTICLE BEAMS 
137 20220091081
 
AROMA DETECTION SYSTEMS FOR FOOD AND BEVERAGE AND CONVERSION OF DETECTED AROMAS TO NATURAL LANGUAGE DESCRIPTORS 
138 20220091083
 
CHEMICAL DETECTION SYSTEM WITH AT LEAST ONE ELECTRONIC NOSE 
139 20220091093
 
MXene Nanopore Sequencer of Biopolymers 
140 20220091099
 
GENE EDITING THROUGH MICROFLUIDIC DELIVERY 
141 20220091100
 
METHOD FOR MEASUREMENT OF LIVE-CELL PARAMETERS FOLLOWED BY MEASUREMENT OF GENE AND PROTEIN EXPRESSION 
142 20220091105
 
METHOD AND APPARATUS FOR DETECTING TARGET CHEMICALS WITH TRANSPARENT INDICATOR TAPE 
143 20220091110
 
Chemically Amplified Detection 
144 20220091111
 
METHODS AND COMPOSITIONS FOR DIAGNOSING NEURODEGENERATIVE DISEASE 
145 20220091121
 
CANCER DETECTION UTILIZING NORMAL TISSUE ADJACENT TO BREAST TUMORS WITH GENETIC ANCESTRY-MAPPING 
146 20220091129
 
REAGENTS AND METHODS FOR DETECTING PROTEIN LYSINE LACTYLATION 
147 20220091130
 
SINGLE MOLECULE PEPTIDE SEQUENCING 
148 20220091133
 
METHODS AND ASSAYS FOR IMMUNE PHENOTYPING 
149 20220091134
 
REAGENTS AND METHODS FOR DETECTING PROTEIN LYSINE 2-HYDROXYISOBUTYRYLATION 
150 20220091174
 
PARTIAL DISCHARGE TRANSDUCER 
151 20220091200
 
Systems And Methods For Increasing The Degree Of Atomic Polarization In Optically Pumped Magnetometers Based On Magnetic Field Zeroing 
152 20220091232
 
Radar Detection of Range Migrating Targets 
153 20220091249
 
Detection of an unknown rank-1 signal in interference and noise with unknown covariance matrix 
154 20220091281
 
NEUTRON AND GAMMA MULTI-ELEMENT ALANINE DOSIMETER HOLDER 
155 20220091288
 
Triple-Mode Detector for Fast Neutrons, Slow Neutrons, and Gamma Ray Spectroscopy 
156 20220091312
 
CONICAL MIRROR CONCENTRATOR FOR A LASER-COOLED COLD ATOM SOURCE 
157 20220091409
 
APERTURE DESIGNS TO MINIMIZE DIFFRACTION NOISE 
158 20220091446
 
OPTICAL COUPLER 
159 20220091474
 
Efficient Spectrum-Spanning Terahertz Frequency Synthesis via Dielectric Structure with Nonlinear Medium 
160 20220091571
 
MULTIMODAL DYNAMIC CHARACTERIZATION OF MATERIALS UNDER PROGRAMMABLE ENVIRONMENTS AND ENVIRONMENT PREDICTION 
161 20220091593
 
MODULAR AND RECONFIGURABLE ASSEMBLER SYSTEM FOR AUTONOMOUS IN-SPACE ASSEMBLY 
162 20220091624
 
LINEAR VOLTAGE REGULATOR 
163 20220091634
 
TACTICAL ASSAULT KIT BOX 
164 20220091844
 
SYSTEM FOR ACHIEVING INSIGHTS THROUGH INTERACTIVE FACET-BASED ARCHITECTURE RECOVERY (I-FAR) 
165 20220091880
 
FINE-GRAINED CONDITIONAL DISPATCHING 
166 20220091980
 
MEMORY ACCESS RESPONSE MERGING IN A MEMORY HIERARCHY 
167 20220092366
 
REGION METRICS FOR CLASS BALANCING IN MACHINE LEARNING SYSTEMS 
168 20220092390
 
SYSTEMS AND METHODS OF COMPONENT-BASED MODELING USING TRAINED SURROGATES 
169 20220092420
 
METHOD, DEVICE, AND STORAGE MEDIUM FOR DEEP LEARNING BASED DOMAIN ADAPTATION WITH DATA FUSION FOR AERIAL IMAGE DATA ANALYSIS 
170 20220092442
 
SYSTEMS, METHODS, AND APPARATUSES FOR EVALUATING WAIT TIMES AND QUEUE LENGTHS AT MULTI-STATION AND MULTI-STAGE SCREENING ZONES VIA A DETERMINISITC DECISION SUPPORT ALGORITHM 
171 20220092609
 
AUTOMATED EVALUATION OF ANTI-COUNTERFEITING MEASURES 
172 20220093271
 
BAYESIAN CAUSAL INFERENCE MODELS FOR HEALTHCARE TREATMENT USING REAL WORLD PATIENT DATA 
173 20220093283
 
COMPACT ASSEMBLY FOR PRODUCTION OF MEDICAL ISOTOPES VIA PHOTONUCLEAR REACTIONS 
174 20220093296
 
PRESERVATION OF STRAIN IN IRON NITRIDE MAGNET 
175 20220093302
 
OPEN-BORE CO-ELECTRODEPOSITION OF METAL MATRIX COMPOSITE COATINGS USING PERMANENT MAGNETS 
176 20220093306
 
STRATEGIES TO PERFORM MAGNETIZATION REVERSALS IN FERROMAGNETS 
177 20220093376
 
Low-Power Mass Interrogation System and Assay For Determining Vitamin D Levels 
178 20220093380
 
METHODS FOR ANALYZING A TISSUE SAMPLE 
179 20220093484
 
WAFER-LEVEL INTEGRATED MICRO-STRUCTURED HEAT SPREADERS 
180 20220093530
 
SELF-ERASABLE AND REWRITABLE OPTOEXCITONIC PLATFORM FOR ANTI-TAMPER HARDWARE 
181 20220093823
 
DEVICE AND METHOD 
182 20220093885
 
IN-SITU GROWTH OF QUANTUM DOTS AND NANO-CRYSTALS FROM ONE, TWO, OR THREE DIMENSIONAL MATERIAL 
183 20220093904
 
METHODS OF FABRICATING POROUS CERAMIC ELECTRODES FOR SOLID STATE BATTERY APPLICATIONS 
184 20220093918
 
COMPOSITE ELECTRODE MATERIALS FOR FLUORIDE-ION ELECTROCHEMICAL CELLS 
185 20220093935
 
STABLE CERAMIC ANODES AND METHODS FOR PRODUCING AND USING THE SAME 
186 20220093960
 
BINDER SYSTEMS AND METHODS FOR TAPE CASTING LITHIUM GARNET ELECTROLYTES 
187 20220093967
 
METHODS FOR WET CHEMICAL SYNTHESIS OF LITHIUM ARGYRODITES AND ENHANCING INTERFACE STABILITY 
188 20220094013
 
AUTOMATIC VENTING SAFETY ENCLOSURE FOR GRID-STORAGE BATTERIES 
189 20220094014
 
EXPLOSIVE ENVIRONMENT NEUTRALIZATION IN CHEMICAL ENERGY STORAGE 
190 20220094029
 
SUPERCONDUCTING VORTEX-BASED MICROWAVE CIRCULATOR 
191 20220094220
 
THREE-DIMENSIONAL AIRGAP ELECTRIC MACHINES EMPLOYING WINDING EMBEDDED LIQUID COOLING 
192 20220094305
 
NON-CONTACT SENSING NODE, SYSTEMS AND METHODS OF REMOTE SENSING 
193 20220094396
 
SYSTEM AND METHOD FOR SELECTIVE TRANSMISSION AND RECEPTION FOR STATIONARY WIRELESS NETWORKS 
194 20220094418
 
Coordination-Free mmWave Beam Management With Deep Waveform Learning 
195 20220094512
 
METHODS AND SYSTEMS FOR SIGNAL INTERFERENCE CANCELLATION 
196 20220094861
 
MULTISPECTRAL IMAGING SENSORS AND SYSTEMS 
197 20220095017
 
SCALABLE LIGHT-WEIGHT PROTOCOLS FOR WIRE-SPEED PACKET ORDERING 

Up to Start Of Table

Patent Applications Count By Department

The count of taxpayer-funded patents granted by the United States Patent and Trademark Office (USPTO) this week that contain a Government Interest Statement in the body of the patent documents or where the government is an assignee. Agency numbers are aggregated by the agency named in the Government Interests Statement and the contract number cited in the patent.

Department This Week This Year
Department of Health and Human Services (HHS) 109 933
Department of Defense (DOD) 42 452
Department of Energy (DOE) 31 342
National Science Foundation (NSF) 29 316
National Aeronautics and Space Administration (NASA) 5 52
Department of Agriculture (USDA) 3 42
Department of Commerce (DOC) 3 14
Department of Veterans Affairs (DVA) 2 23
Small Business Administration (SBA) 2 38
Department of Homeland Security (DHS) 1 23
National Reconnaissance Office (NRO) 1 2
National Security Agency (NSA) 1 7
United States Postal Service (USPS) 1 9
Government Rights Acknowledged 1 11

Patent Applications by Funding Agency

FedInvent Patents reflects patents with Government Interests Statements in the body of the patent as required by the Bayh-Dole Act indicating the holder of a federal contract, grant, or cooperative agreement has elected to retain the title of inventions conceived and reduced to practice during that contract; and patents where an agency of the US Federal government has elected to retain the title to the patent.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent you are interested appears at the top of the list on the details page.

Click the Panel to See The Patent Application for Each Agency

Take Me To The Details
Patent Title
001 20220087285
 
DIETARY EARLY GLYCATION PRODUCTS FOR TREATING AND PREVENTING AUTOIMMUNE DISEASES 
002 20220087595
 
METHOD FOR CHARACTERIZATION OF THE FEMALE PELVIC FLOOR WITH A BIOMECHANICAL INTEGRITY SCORE 
003 20220087651
 
Systems and Methods for Microvessel Ultrasound Imaging 
004 20220087813
 
ANTI-PULFRICH MONOVISION OPHTHALMIC CORRECTION 
005 20220087817
 
Prosthetic Heart Valve with Tri-Leaflet Design for Use in Percutaneous Valve Replacement Procedures 
006 20220087860
 
METHOD AND SYSTEM FOR REGULATING CORE BODY TEMPERATURE 
007 20220087930
 
SARS-CoV-2 Subunit Vaccine and Microneedle Array Delivery System 
008 20220087950
 
COMPOUNDS, TARGETS AND PATHWAYS FOR MACROPHAGE MODULATION 
009 20220087954
 
USE OF 2-HYDROXYBENZYLAMINE FOR THE TREATMENT OF SYSTEMIC LUPUS 
010 20220087970
 
PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION 
011 20220087977
 
METHODS FOR THE PREVENTION OR TREATMENT OF CYTOKINE STORM 
012 20220087992
 
COMPOUNDS AND METHODS OF TREATING RETINAL DEGENERATION 
013 20220088010
 
Co-Administration of inhibitors to produce insulin producing gut cells 
014 20220088019
 
PAC-1 COMBINATION THERAPY 
015 20220088026
 
METHODS OF TREATING TYROSINE KINASE INHIBITOR-INDUCED DIARRHEA 
016 20220088031
 
METHODS AND COMPOSITIONS FOR TREATING RESISTANT AND RECURRENT FORMS OF CANCER 
017 20220088053
 
Usb1 Directed Regulation Of Mirnas Related Hematopoietic Differentiation And Affected In Multiple Forms Of Leukemia 
018 20220088058
 
ANTISENSE OLIGOMERS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION-5 AND DRAVET SYNDROME 
019 20220088065
 
Inorganic Nitrite to Improve Cardiopulmonary Hemodynamics 
020 20220088117
 
SERINE PROTEINASE INHIBITORS: SERP-1 AND SERP-1 RCL-DERIVED PEPTIDES EFFECT ON MICROBIOME COMPOSITION AND USES THEREOF 
021 20220088119
 
THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE 
022 20220088127
 
TARGETING THE BAG FAMILY FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE 
023 20220088145
 
IMMUNOTHERAPY FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY BOWEL DISEASE 
024 20220088152
 
COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATPASE-MEDIATED DISEASES 
025 20220088163
 
HYBRID IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY 
026 20220088164
 
ANTI-MUTATED KRAS T CELL RECEPTORS 
027 20220088170
 
METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION 
028 20220088171
 
IMMUNOGENIC COMPOSITIONS AND USES THEREOF 
029 20220088174
 
GENOMIC VARIANTS IN IG GENE REGIONS AND USES OF SAME 
030 20220088180
 
IMMUNOGENIC COMPOSITIONS AND USE THEREOF 
031 20220088183
 
CHIMERIC ONCOLYTIC HERPESVIRUS THAT STIMULATES AN ANTITUMOR IMMUNE RESPONSE 
032 20220088185
 
PASSIVE TRANSFER OF IMMUNITY USING RECOMBINANT HERPES SIMPLEX VIRUS 2 (HSV-2) VACCINE VECTORS 
033 20220088204
 
ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME 
034 20220088208
 
PHLIP®-MEDIATED INTRACELLULAR DELIVERY OF IMMUNO-STIMULATORY COMPOUNDS 
035 20220088211
 
O-LINKED GLYCOSYLATION RECOGNITION MOTIFS 
036 20220088215
 
METHODS OF MAKING TARGETED VESICLES, AND COMPOSITIONS MADE THEREBY 
037 20220088216
 
VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS 
038 20220088222
 
COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES 
039 20220088228
 
ROD-SHAPED PLANT VIRUS NANOPARTICLES AS IMAGING AGENT PLATFORMS 
040 20220088229
 
PSMA-BINDING AGENTS AND USES THEREOF 
041 20220088268
 
PARTICULATE COATED HYDROGEL MICROPARTICLES 
042 20220088274
 
Targeted in Situ Therapeutic Delivery of Secreted Factors from Stem Cells for Treatment of Damaged Tissue 
043 20220088304
 
SYSTEMS AND METHODS FOR CLOSED-LOOP CONTROL OF INSULIN-GLUCOSE DYNAMICS 
044 20220088417
 
METHOD FOR OPTIMIZING RADIATION BEAM INTENSITY PROFILE SHAPE USING DUAL MULTIPLE APERTURE DEVICES 
045 20220088556
 
Aqueous Systems Of At Least Two Phases Containing Microcapsules And Processes For Manufacturing The Same 
046 20220088588
 
MULTI-DIMENSIONAL DOUBLE SPIRAL DEVICE AND METHODS OF USE THEREOF 
047 20220088601
 
Method and System for Sample Collection, Storage, Preparation and Detection 
048 20220089537
 
HIGH-THROUGHPUT METHOD TO RAPIDLY ADD CHEMICAL MOIETIES TO A SMALL MOLECULE LIBRARY 
049 20220089549
 
INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF 
050 20220089565
 
MODULATORS OF P97 AAA ATPASE ACTIVITY 
051 20220089576
 
ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS 
052 20220089577
 
KU INHIBITORS AND THEIR USE 
053 20220089579
 
BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS 
054 20220089581
 
INHIBITORS OF SPINSTER HOMOLOG 2 (SPNS2) FOR USE IN THERAPY 
055 20220089602
 
COMPOUNDS THAT INDUCE FERROPTIC CELL DEATH 
056 20220089616
 
CARBORANE-BASED HISTONE DEACETYLASE (HDAC) INHIBITORS 
057 20220089638
 
DITHIOCARBAMATE STAPLED PEPTIDES AND METHODS OF MAKING AND USE THEREOF 
058 20220089644
 
C1q AND HMGB1 FUSION PROTEINS AND USES THEREOF 
059 20220089651
 
METHODS AND COMPOSITIONS FOR ANTIBODY-EVADING VIRUS VECTORS 
060 20220089660
 
IDENTIFICATION OF MUTATIONS IN CHANNELOPSIN VARIANTS HAVING IMPROVED LIGHT SENSITIVITY AND METHODS OF USE THEREOF 
061 20220089665
 
Peptide Compounds and Methods of Use in Wound Healing 
062 20220089670
 
Gene Therapy for BEST1 Dominant Mutations 
063 20220089673
 
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION 
064 20220089677
 
ANTI-KRAS-G12D T CELL RECEPTORS 
065 20220089694
 
EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF 
066 20220089696
 
ARENAVIRUS MONOCLONAL ANTIBODIES AND USES 
067 20220089717
 
MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4) 
068 20220089752
 
COMPOSITIONS AND METHODS FOR MODULATING CELLULAR INTERNALIZATION 
069 20220089777
 
NOVEL HUMANIZED ANTIBODIES AGAINST FACTOR XI HAVING ANTI-THROMBOTIC AND ANTI-INFLAMMATORY EFFECT AND USES THEREOF 
070 20220089784
 
Antibodies for Botulinum Neurotoxins 
071 20220089821
 
HYDROGEL-ENCAPSULATED BETA CELLS, BETA-CELL ENCAPSULATION PROCESS, AND USES THEREOF 
072 20220090000
 
APPARATUS AND PROCESSES FOR ISOLATING BIOLOGICAL MATERIAL 
073 20220090009
 
HUMAN PLURIPOTENT STEM CELL-BASED SYSTEM FOR GENERATING ENDOTHELIAL CELLS 
074 20220090021
 
IN VITRO HUMAN BLOOD BRAIN BARRIER 
075 20220090026
 
VIRAL NANOPARTICLE MULTIMERS 
076 20220090055
 
MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO CARBOHYDRATE-BINDING MONOCLONAL ANTIBODY FAMILY PGT128 
077 20220090070
 
METHODS AND COMPOSITIONS FOR ALTERING FUNCTION AND STRUCTURE OF CHROMATIN LOOPS AND/OR DOMAINS 
078 20220090071
 
SPINAL MUSCULAR ATROPHY (SMA) TREATMENT VIA TARGETING OF SMN2 SPLICE SITE INHIBITORY SEQUENCES 
079 20220090076
 
5-HALOURACIL-MODIFIED MICRORNAS AND THEIR USE IN THE TREATMENT OF CANCER 
080 20220090079
 
Methods and Compositions for Managing Vascular Conditions Using miR-483 Mimics and HIF1alpha Pathway Inhibitors 
081 20220090083
 
TARGETING EGLN1 IN CANCER 
082 20220090086
 
IDENTIFICATION OF MOLECULAR PATHWAYS AND METHODS OF USE THEREOF FOR TREATING RETINAL NEURODEGENERATION AND OTHER NEURODEGENERATIVE DISORDERS 
083 20220090089
 
ENGINEERED MULTI-OMIC DISPLAY CONSTRUCTS AND DISPLAY SYSTEMS 
084 20220090097
 
REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY 
085 20220090137
 
METHODS AND COMPOSITIONS FOR CIRCULAR RNA MOLECULES 
086 20220090139
 
DESIGN OF BACTERIOPHAGE-BASED ARTIFICIAL VIRUSES FOR HUMAN GENOME REMODELING 
087 20220090145
 
RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci 
088 20220090146
 
ATTB CELL LINE, TRANSGENIC CELL LINES DERIVED THEREFROM, AND METHODS OF MAKING THE SAME 
089 20220090163
 
FRACTIONAL INITIATOR HYBRIDIZATION CHAIN REACTION 
090 20220090164
 
METHODS FOR THE DETECTION OF DNA-RNA PROXIMITY IN VIVO 
091 20220090167
 
ASYMMETRIC NANOPORE MEMBRANE (ANM) FILTRATION FOR HIGH-EFFICIENCY VIRUS ENRICHMENT AND PURIFICATION 
092 20220090176
 
Methods of Epigenetic Analysis 
093 20220090178
 
DEVICES FOR CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS 
094 20220090201
 
CLINICAL ASSESSMENT OF CEREBRAL VASOSPASM RISK FOLLOWING ANEURYSMAL SUBARACHNOID HEMORRHAGE 
095 20220090203
 
NON-INVASIVE BLOOD BASED MONITORING OF GENOMIC ALTERATIONS IN CANCER 
096 20220090206
 
COLORECTAL CANCER RECURRENCE GENE EXPRESSION SIGNATURE 
097 20220091014
 
METHOD AND SYSTEM FOR IMPEDANCE-BASED QUANTIFICATION AND MICROFLUIDIC CONTROL 
098 20220091040
 
BIOLOGICAL SENSING AND COMMUNICATION USING OPTOGENETICS AND ELECTRONICS 
099 20220091044
 
OPTICAL CAVITY SURFACE BIOCONJUNCTION USING LIPID MEMBRANES FOR LABEL FREE, ULTRASENSITIVE DETECTION OF BIOMOLECULES 
100 20220091099
 
GENE EDITING THROUGH MICROFLUIDIC DELIVERY 
101 20220091100
 
METHOD FOR MEASUREMENT OF LIVE-CELL PARAMETERS FOLLOWED BY MEASUREMENT OF GENE AND PROTEIN EXPRESSION 
102 20220091111
 
METHODS AND COMPOSITIONS FOR DIAGNOSING NEURODEGENERATIVE DISEASE 
103 20220091129
 
REAGENTS AND METHODS FOR DETECTING PROTEIN LYSINE LACTYLATION 
104 20220091130
 
SINGLE MOLECULE PEPTIDE SEQUENCING 
105 20220091133
 
METHODS AND ASSAYS FOR IMMUNE PHENOTYPING 
106 20220091134
 
REAGENTS AND METHODS FOR DETECTING PROTEIN LYSINE 2-HYDROXYISOBUTYRYLATION 
107 20220091200
 
Systems And Methods For Increasing The Degree Of Atomic Polarization In Optically Pumped Magnetometers Based On Magnetic Field Zeroing 
108 20220093271
 
BAYESIAN CAUSAL INFERENCE MODELS FOR HEALTHCARE TREATMENT USING REAL WORLD PATIENT DATA 
109 20220093380
 
METHODS FOR ANALYZING A TISSUE SAMPLE 

Up to Start Of Table

Take Me To The Details

Department of Defense (DOD) Agencies

Patent Title
001 20220087595
 
METHOD FOR CHARACTERIZATION OF THE FEMALE PELVIC FLOOR WITH A BIOMECHANICAL INTEGRITY SCORE 
002 20220088092
 
COMPOSITIONS AND METHODS FOR INCREASING THE VIABILITY OF FREEZE-DRIED PROBIOTICS 
003 20220088133
 
Nanoliposome Compositions And Methods Of Treating Stroke 
004 20220088274
 
Targeted in Situ Therapeutic Delivery of Secreted Factors from Stem Cells for Treatment of Damaged Tissue 
005 20220089611
 
INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF 
006 20220089784
 
Antibodies for Botulinum Neurotoxins 
007 20220090092
 
ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN EXPRESSION 
008 20220090145
 
RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci 
009 20220090163
 
FRACTIONAL INITIATOR HYBRIDIZATION CHAIN REACTION 
010 20220090587
 
PROPELLANT APPARATUS 
011 20220091105
 
METHOD AND APPARATUS FOR DETECTING TARGET CHEMICALS WITH TRANSPARENT INDICATOR TAPE 
012 20220091200
 
Systems And Methods For Increasing The Degree Of Atomic Polarization In Optically Pumped Magnetometers Based On Magnetic Field Zeroing 
013 20220095017
 
SCALABLE LIGHT-WEIGHT PROTOCOLS FOR WIRE-SPEED PACKET ORDERING 

Department of the ARMY (DOA)

Patent Title
001 20220087595
 
METHOD FOR CHARACTERIZATION OF THE FEMALE PELVIC FLOOR WITH A BIOMECHANICAL INTEGRITY SCORE 
002 20220088133
 
Nanoliposome Compositions And Methods Of Treating Stroke 
003 20220088229
 
PSMA-BINDING AGENTS AND USES THEREOF 
004 20220088274
 
Targeted in Situ Therapeutic Delivery of Secreted Factors from Stem Cells for Treatment of Damaged Tissue 
005 20220089611
 
INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF 
006 20220089989
 
DEVICES FOR SIMULATING A FUNCTION OF A TISSUE AND METHODS OF USE AND MANUFACTURING THEREOF 
007 20220090136
 
SIN NOMBRE VIRUS FULL-LENGTH M SEGMENT-BASED DNA VACCINES 
008 20220090145
 
RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci 
009 20220091019
 
CONTACT-FREE HOLOGRAPHIC IMAGING OF AEROSOL PARTICLES FROM MOBILE PLATFORMS 
010 20220091105
 
METHOD AND APPARATUS FOR DETECTING TARGET CHEMICALS WITH TRANSPARENT INDICATOR TAPE 
011 20220091121
 
CANCER DETECTION UTILIZING NORMAL TISSUE ADJACENT TO BREAST TUMORS WITH GENETIC ANCESTRY-MAPPING 
012 20220091312
 
CONICAL MIRROR CONCENTRATOR FOR A LASER-COOLED COLD ATOM SOURCE 
013 20220092366
 
REGION METRICS FOR CLASS BALANCING IN MACHINE LEARNING SYSTEMS 
014 20220093302
 
OPEN-BORE CO-ELECTRODEPOSITION OF METAL MATRIX COMPOSITE COATINGS USING PERMANENT MAGNETS 

Department of the Navy (DON) | United States Marine Corps (USMC)

Patent Title
001 20220087565
 
SMART ELASTIC FABRIC TAPE FOR DISTRIBUTED SKIN STRAIN, MOVEMENT, AND MUSCLE ENGAGEMENT MONITORING 
002 20220088028
 
NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR PARTIAL AGONISTS AS THERAPEUTICS FOR CHRONIC TINNITUS 
003 20220090788
 
TRAPPED VORTEX COMBUSTOR FOR A GAS TURBINE ENGINE WITH A DRIVER AIRFLOW CHANNEL 
004 20220090917
 
THREE DIMENSIONAL MICROSTRUCTURES WITH SELECTIVELY REMOVED REGIONS FOR USE IN GYROSCOPES AND OTHER DEVICES 
005 20220091110
 
Chemically Amplified Detection 
006 20220091130
 
SINGLE MOLECULE PEPTIDE SEQUENCING 
007 20220091232
 
Radar Detection of Range Migrating Targets 
008 20220091281
 
NEUTRON AND GAMMA MULTI-ELEMENT ALANINE DOSIMETER HOLDER 
009 20220094861
 
MULTISPECTRAL IMAGING SENSORS AND SYSTEMS 

Department of the Air Force (DAF)| United States Space Force (USSF)

Patent Title
001 20220090587
 
PROPELLANT APPARATUS 
002 20220090882
 
DEPLOYABLE ORIGAMI-INSPIRED BARRIERS 
003 20220091249
 
Detection of an unknown rank-1 signal in interference and noise with unknown covariance matrix 
004 20220091634
 
TACTICAL ASSAULT KIT BOX 
005 20220092420
 
METHOD, DEVICE, AND STORAGE MEDIUM FOR DEEP LEARNING BASED DOMAIN ADAPTATION WITH DATA FUSION FOR AERIAL IMAGE DATA ANALYSIS 
006 20220093376
 
Low-Power Mass Interrogation System and Assay For Determining Vitamin D Levels 
007 20220093484
 
WAFER-LEVEL INTEGRATED MICRO-STRUCTURED HEAT SPREADERS 
008 20220093530
 
SELF-ERASABLE AND REWRITABLE OPTOEXCITONIC PLATFORM FOR ANTI-TAMPER HARDWARE 
009 20220093823
 
DEVICE AND METHOD 
010 20220094305
 
NON-CONTACT SENSING NODE, SYSTEMS AND METHODS OF REMOTE SENSING 
011 20220094512
 
METHODS AND SYSTEMS FOR SIGNAL INTERFERENCE CANCELLATION 
012 20220094861
 
MULTISPECTRAL IMAGING SENSORS AND SYSTEMS 

Up to Start Of Table

Take Me To The Details
Patent Title
001 20220088163
 
HYBRID IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY 
002 20220088868
 
SYSTEM AND METHOD FOR ROLL-TO-ROLL FILM TENSIONING FOR REDUCED SEPARATION FORCE DURING BOTTOM-UP STEREOLITHOGRAPHY 
003 20220088876
 
ADDITIVE MANUFACTURING SYSTEM WITH AT LEAST ONE ELECTRONIC NOSE 
004 20220088881
 
SYSTEM AND METHOD FOR SIMULATION-ASSISTED ADDITIVE MANUFACTURING 
005 20220089483
 
SYSTEMS AND METHODS FOR MOISTURE CONDITIONING AGGREGATE WITH AN ALKALINE COMPOUND 
006 20220089654
 
MUTANT TRANSPORTERS FOR BACTERIAL UPTAKE OF TEREPHTHALIC ACID 
007 20220091032
 
Two-Dimensional Second Harmonic Dispersion Interferometer 
008 20220091064
 
SILVER-SILVER SULFIDE REFERENCE ELECTRODE 
009 20220091081
 
AROMA DETECTION SYSTEMS FOR FOOD AND BEVERAGE AND CONVERSION OF DETECTED AROMAS TO NATURAL LANGUAGE DESCRIPTORS 
010 20220091083
 
CHEMICAL DETECTION SYSTEM WITH AT LEAST ONE ELECTRONIC NOSE 
011 20220091099
 
GENE EDITING THROUGH MICROFLUIDIC DELIVERY 
012 20220091174
 
PARTIAL DISCHARGE TRANSDUCER 
013 20220091288
 
Triple-Mode Detector for Fast Neutrons, Slow Neutrons, and Gamma Ray Spectroscopy 
014 20220091446
 
OPTICAL COUPLER 
015 20220091571
 
MULTIMODAL DYNAMIC CHARACTERIZATION OF MATERIALS UNDER PROGRAMMABLE ENVIRONMENTS AND ENVIRONMENT PREDICTION 
016 20220091844
 
SYSTEM FOR ACHIEVING INSIGHTS THROUGH INTERACTIVE FACET-BASED ARCHITECTURE RECOVERY (I-FAR) 
017 20220091880
 
FINE-GRAINED CONDITIONAL DISPATCHING 
018 20220091980
 
MEMORY ACCESS RESPONSE MERGING IN A MEMORY HIERARCHY 
019 20220092390
 
SYSTEMS AND METHODS OF COMPONENT-BASED MODELING USING TRAINED SURROGATES 
020 20220092609
 
AUTOMATED EVALUATION OF ANTI-COUNTERFEITING MEASURES 
021 20220093283
 
COMPACT ASSEMBLY FOR PRODUCTION OF MEDICAL ISOTOPES VIA PHOTONUCLEAR REACTIONS 
022 20220093296
 
PRESERVATION OF STRAIN IN IRON NITRIDE MAGNET 
023 20220093306
 
STRATEGIES TO PERFORM MAGNETIZATION REVERSALS IN FERROMAGNETS 
024 20220093904
 
METHODS OF FABRICATING POROUS CERAMIC ELECTRODES FOR SOLID STATE BATTERY APPLICATIONS 
025 20220093935
 
STABLE CERAMIC ANODES AND METHODS FOR PRODUCING AND USING THE SAME 
026 20220093960
 
BINDER SYSTEMS AND METHODS FOR TAPE CASTING LITHIUM GARNET ELECTROLYTES 
027 20220093967
 
METHODS FOR WET CHEMICAL SYNTHESIS OF LITHIUM ARGYRODITES AND ENHANCING INTERFACE STABILITY 
028 20220094013
 
AUTOMATIC VENTING SAFETY ENCLOSURE FOR GRID-STORAGE BATTERIES 
029 20220094014
 
EXPLOSIVE ENVIRONMENT NEUTRALIZATION IN CHEMICAL ENERGY STORAGE 
030 20220094220
 
THREE-DIMENSIONAL AIRGAP ELECTRIC MACHINES EMPLOYING WINDING EMBEDDED LIQUID COOLING 
031 20220094396
 
SYSTEM AND METHOD FOR SELECTIVE TRANSMISSION AND RECEPTION FOR STATIONARY WIRELESS NETWORKS 

Up to Start Of Table

Take Me To The Details
Patent Title
001 20220087607
 
PHYSIOLOGICAL SENSING TEXTILE APPARATUS 
002 20220088163
 
HYBRID IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY 
003 20220088226
 
PYRIMIDINE NUCLEOSIDE COMPOUNDS FOR FLUORESCENCE IMAGING AND SPECTROSCOPY 
004 20220088228
 
ROD-SHAPED PLANT VIRUS NANOPARTICLES AS IMAGING AGENT PLATFORMS 
005 20220088555
 
SELF-STABILIZED THERMOTHICKENING COLLOIDS 
006 20220088556
 
Aqueous Systems Of At Least Two Phases Containing Microcapsules And Processes For Manufacturing The Same 
007 20220088846
 
MULTILAYERED STRUCTURES AND USES THEREOF IN SECURITY MARKINGS 
008 20220089487
 
OIL-TREATED PLASTIC FOR CONCRETE 
009 20220089496
 
HIERARCHICAL ORGANIC-INORGANIC COMPOSITES SYNTHESIZED BY ELECTROSPINNING FIBERS WITHIN A NON-CONDUCTIVE AND A CONDUCTIVE PRE-CERAMIC GEL 
010 20220089508
 
Non-Cryogenic, Ammonia-Free Reduction of Aryl Compounds 
011 20220089537
 
HIGH-THROUGHPUT METHOD TO RAPIDLY ADD CHEMICAL MOIETIES TO A SMALL MOLECULE LIBRARY 
012 20220089821
 
HYDROGEL-ENCAPSULATED BETA CELLS, BETA-CELL ENCAPSULATION PROCESS, AND USES THEREOF 
013 20220090000
 
APPARATUS AND PROCESSES FOR ISOLATING BIOLOGICAL MATERIAL 
014 20220090026
 
VIRAL NANOPARTICLE MULTIMERS 
015 20220090027
 
ENGINEERED POLYPEPTIDES THAT EXHIBIT INCREASED CATALYTIC EFFICIENCY FOR UNNATURAL COFACTORS AND USES THEREOF 
016 20220090139
 
DESIGN OF BACTERIOPHAGE-BASED ARTIFICIAL VIRUSES FOR HUMAN GENOME REMODELING 
017 20220090163
 
FRACTIONAL INITIATOR HYBRIDIZATION CHAIN REACTION 
018 20220090200
 
DNA METHYLATION MEASUREMENT FOR MAMMALS BASED ON CONSERVED LOCI 
019 20220090300
 
FOCUSED ROTARY JET SPINNING DEVICES AND METHODS OF USE THEREOF 
020 20220090811
 
DETECTING PRESENCE AND ESTIMATING THERMAL COMFORT OF ONE OR MORE HUMAN OCCUPANTS IN A BUILT SPACE IN REAL-TIME USING ONE OR MORE THERMOGRAPHIC CAMERAS AND ONE OR MORE RGB-D SENSORS 
021 20220090882
 
DEPLOYABLE ORIGAMI-INSPIRED BARRIERS 
022 20220091093
 
MXene Nanopore Sequencer of Biopolymers 
023 20220091624
 
LINEAR VOLTAGE REGULATOR 
024 20220093380
 
METHODS FOR ANALYZING A TISSUE SAMPLE 
025 20220093885
 
IN-SITU GROWTH OF QUANTUM DOTS AND NANO-CRYSTALS FROM ONE, TWO, OR THREE DIMENSIONAL MATERIAL 
026 20220093967
 
METHODS FOR WET CHEMICAL SYNTHESIS OF LITHIUM ARGYRODITES AND ENHANCING INTERFACE STABILITY 
027 20220094014
 
EXPLOSIVE ENVIRONMENT NEUTRALIZATION IN CHEMICAL ENERGY STORAGE 
028 20220094029
 
SUPERCONDUCTING VORTEX-BASED MICROWAVE CIRCULATOR 
029 20220094418
 
Coordination-Free mmWave Beam Management With Deep Waveform Learning 

Up to Start Of Table

Emerging Technology

Emerging Climate Change Technologies

Patents containing 'Y" CPC symbols indicate emerging technologies important to US scientific leadership.

Patent documents that contain a Y02 or Y04 CPC symbol are already classified elsewhere. USPTO add the Y symbols to the classification data is to monitor new technological development covering clean technology and inventions impacting climate change, important American science and technology interests.

Y02 — Green House Gas Mitigation — Y02 covers selected technologies, which control, reduce or prevent anthropogenic emissions of greenhouse gases (GHG), in the framework of the Kyoto Protocol and the Paris Agreement, and technologies that allow adapting to the adverse effects of climate change. Y02A covers technologies for adaptation to climate change, — technologies that allow adapting to the adverse effects of climate change in human, industrial (including agriculture and livestock), and economic activities. Y02P covers climate change mitigation technologies in any kind of industrial processing or production activity, including the agroalimentary industry (relating to agriculture and food), agriculture, fishing, ranching, and the like.

Y04 — Enabling Technologies — Y04 is focused on the information and communications inventions that facilitate climate change technology. Y04S covers systems integrating technologies related to power network operation, communication or information technologies for improving electrical power generation, transmission, distribution, management, or usage. Examples of the art covered here are technologies related to smart grids, home appliances, and systems supporting the interoperability of electric or hybrid vehicles.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent application you are interested appears at the top of the list on the details page.
Class
Y02P Climate Change Mitigation Technologies in the Production or Processing of Goods
20220088229  PSMA-BINDING AGENTS AND USES THEREOF      

Count of patent applications funded by The Department of Health and Human Services (HHS).

Department | Agency This Week This Year
Department of Health and Human Services (HHS)109933
National Institutes of Health (NIH)105896
National Cancer Institute (NCI)21226
Frederick National Laboratory for Cancer Research (FNLCR)12
National Institute of General Medical Sciences (NIGMS)19146
IDeA Networks of Biomedical Research Excellence (INBRE)23
National Institute of Allergy and Infectious Diseases (NIAID)18140
National Heart, Lung, and Blood Institute (NHLBI)15112
National Eye Institute (NEI)1039
National Institute of Biomedical Imaging and Bioengineering (NIBIB)780
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)660
National Human Genome Research Institute (NHGRI)522
National Institute of Neurological Disorders and Stroke (NINDS)469
National Institute of Mental Health (NIMH)434
National Center for Advancing Translational Sciences (NCATS)422
NIH Office of the Director (NIHOD)316
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)321
National Institute on Aging (NIA)339
National Institute of Environmental Health Sciences (NIEHS)212
National Institute on Drug Abuse (NIDA)216
National Center for Research Resources (NCRR)211
National Institute of Dental and Craniofacial Research (NIDCR)115
National Institute of Child Health and Human Development (NICHD)123
National Center for Complementary and Integrative Health (NCCIH)13
U.S. Public Health Service (USPHS)13
Centers for Disease Control and Prevention (CDC)16

Up to Start Of Table

Higher Education Research and Development (HERD)

FedInvent follows the HERD the Higher Education Research and Development institutions — the colleges and universities; research institutions, and medical schools that benefit from federal funding and rely on it to make important discoveries that drive American innovation. Taxpayer funded patents coming from mostly American and sometime foreign universities are an important indicia of the vitality of the American innovation ecosphere.

MEMBERS OF THE HERD

The National Science Foundation (NSF) Higher Education Research and Development (HERD) Survey is the primary source of information on R&D expenditures at 916 US colleges and universities that expended at least $150,000 in separately accounted for R&D in the fiscal year. We use the NSF list to keep track of which colleges and universities are receiving taxpayer-funded patents and filing patent applications.

WATCH This SPACE

We're working on our data analytics and will be reporting taxpayer-funded patents and patent applications shortly. In the meantime, FedInvent will post interesting information about the HERD Innovation Ecosphere here.

Top Ten Universities By R&D Expenditures
  1. Johns Hopkins University
  2. University of Michigan
  3. University of Washington
  4. University of California, San Diego
  5. University of California, San Francisco
  6. Columbia University in the City of New York
  7. Stanford University
  8. University Pittsburgh
  9. University Pennsylvania
  10. Duke University

Patent Applications by Scientific Domain.

This section contains the number of patents organiized by high level scientific and technical domain. The data is arranged by the first Cooperative Patent Classification System (CPC) patent symbol assigned to the patent. This indicates the scope and nature of the patented invention for a patent or a patent application.

Global patent offices use patent classification as their lingua franca — the common language — for exchanging information about inventions and what scientific and technical art a patent contains. The classifications assigned to a patent are used by patent examiners to find prior art and to determine if a particular patent's claims are novel. Patent classifications are also used for global enforcement of patent rights, treaties, and agreements.

Class Class Definition First
(Original)
Inventive
(CrossRef)
CPC A61 Medical or Veterinary Science; Hygiene 50 256
CPC C12 Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or Genetic Engineering 30 182
CPC G01 Measuring; Testing 27 96
CPC C07 Organic Chemistry 26 69
CPC H01 Basic Electric Elements 17 41
CPC G06 Computing; Calculating; Counting 9 35
CPC B01 Physical or Chemical Processes or Apparatus in General 4 31
CPC H04 Electric Communication Technique 5 22
CPC G02 Optics 4 12
CPC B29 Working of Plastics; Working of Substances in a Plastic State in General 4 11
CPC B32 Layered Products 0 15
CPC C08 Organic Macromolecular Compounds; Their Preparation or Chemical Working-up; Compositions Based Thereon 2 12
CPC G21 Nuclear Physics; Nuclear Engineering 1 6
CPC C04 Cements; Concrete; Artificial Stone; Ceramics; Refractories 3 3
CPC G05 Controlling; Regulating 3 3
CPC D01 Edible products 2 3
CPC G16 Information and Communication Technology [ICT] Specially Adapted for Specific Application Fields 1 4
CPC F23 Combustion Apparatus; Combustion Processes 1 3
CPC F41 Weapons 1 3
CPC H03 Basic Electronic Circuitry 1 3
CPC B65 Conveying; Packing; Storing; Handling Thin or Filamentary Material 1 2
CPC H02 Generation; Conversion or Distribution of Electric Power 1 2
CPC A23 Foods or Foodstuffs; Treatment Thereof, Not Covered by Other Classes 1 1
CPC C01 Inorganic Chemistry 1 1
CPC F01 Machines or Engines in General; Engine Plants in General; Steam Engines 1 1
CPC F24 Heating; Ranges; Ventilating 1 1
CPC F03 Machines or Engines for Liquids; Wind, Spring, or Weight Motors; Producing Mechanical Power or a Reactive Propulsive Thrust, Not Otherwise Provided for 1 0
CPC Y02 Technologies or Applications for Mitigation or Adaptation Against Climate Change 0 1

Up to Start Of Table

Count of Inventors by Country and U.S. State

Patent Applications by country and state based on location information of first named inventors and all listed inventors.

Country First Named Inventors All Inventors
United States of America 194 637
Germany 2 7
China PRC 1 4
Australia 0 9
Spain 0 3
Netherlands 0 3
Japan 0 2
Sweden 0 2
Chile 0 1
United Kingdom 0 1
Israel 0 1
India 0 1
Italy 0 1
New Zealand 0 1
U.S. State First Named Inventors All Inventors
Massachusetts 32 111
California 28 90
Maryland 13 46
Illinois 11 32
Ohio 11 31
Pennsylvania 9 22
Virginia 8 38
Arizona 8 29
New York 6 20
Tennessee 6 13
Texas 5 31
North Carolina 5 17
Michigan 5 15
Indiana 4 11
Georgia 3 13
Florida 3 10
Connecticut 3 8
New Jersey 3 8
Colorado 3 6
Kentucky 3 6
Wisconsin 3 5
Utah 2 11
Washington 2 10
Missouri 2 7
Minnesota 2 6
Wyoming 2 6
District of Columbia 2 4
Oregon 2 4
Alabama 1 7
Iowa 1 4
Oklahoma 1 3
Rhode Island 1 3
Kansas 1 2
Nebraska 1 2
South Carolina 1 2
Idaho 1 1
Louisiana 0 2
Nevada 0 1

Up to Start Of Table

Count of Assignees and Applicants by Country and U.S. State

Patent Applications by country and state based on location information of Assignees and Applicants.

Country Assignees Applicants
United States of America 55238
China PRC 22
Germany 11
Mexico 11
Netherlands 02
Denmark 01
Italy 01
Japan 01
Spain 01
United Kingdom 01
U.S. State Assignees Applicants
Massachusetts 1648
California 829
Maryland 821
Illinois 311
Virginia 37
Ohio 212
New York 211
Pennsylvania 28
Texas 27
Arizona 110
Florida 15
North Carolina 15
Michigan 14
Connecticut 13
Kentucky 13
Alabama 12
Rhode Island 11
Washington 11
District of Columbia 09
Tennessee 06
Missouri 05
Georgia 04
Indiana 04
Colorado 03
New Jersey 03
Minnesota 02
Oregon 02
Utah 02
Wisconsin 02
Wyoming 02
Iowa 01
Louisiana 01
Nebraska 01
Nevada 01
Oklahoma 01
South Carolina 01

Up to Start Of Table

Technology Center Explainer

How Tech Centers and Art Units Are Organized And Why It Matters

Patents travel from Technology Center to Art Unit to Group Art Unit to Patent Examiner.

The USPTO's patent corps is organized into Technology Centers (TCs), groups of patent examiners with specific scientific and technical domain expertise. Technology Centers are further divided into Art Units (AUs) organized by major types of inventive art within a scientific or technical domain. Art Units are organized into Group Art Units, even more specialized and granular teams of examiners.

Group Art Units (GAUs) are where patent examiners prosecute patent applications. Patent applications are docketed to examiners based on of specific subject matter classifications of a particular GAU.

Understanding Technology Centers, Art Units and Group Art Units helps you understand what type of inventions are being prosecuted within each scientific and technical domain, how long it takes from the date a patent application is filed to the time a final decision on the patentability of the invention is made.

Patents examined here cover:

Art Unit Technical & Scientific Domains
1610 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
1620 Organic Chemistry
1630 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
1640 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
1650 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzyme
1660 Plants

About Plant Patents

Plant Patents are granted by the Government to an inventor who has invented or discovered and asexually reproduced a distinct and new variety of plant, other than a tuber propagated plant or a plant found in an uncultivated state. If you've ever eaten a pluot, you've enjoyed the fruit of a plant patent.

Plant patent numbers begin with a "PP" followed by a five digit number. The first Plant Patent was issued in 1931. Plant patents are valid for 20 years from the filing date.

Patents examined here cover:

Art Unit Technical & Scientific Domains
1710 Coating, Etching, Cleaning, Single Crystal Growth
1720 Fuel Cells, Batteries, Solar Cells, Liquid Crystal Composition
1730 Metallurgy, Metal Working, Inorganic Chemistry, Catalysts, Electrophotography, Photolithography
1740 Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
1760 Organic Chemistry, Polymers, Compositions
1770 Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
1780 Miscellaneous Articles, Stock Material, Adhesive Composition, Fabrics
1790 Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry

Patents examined here cover:

Art Unit Technical & Scientific Domains
2110 Coating, Etching, Cleaning, Single Crystal Growth
2120 Miscellaneous Articles, Stock Material, Adhesive Composition, Fabrics
2130 Fuel Cells, Batteries, Solar Cells, Liquid Crystal Composition
2140/2170 Metallurgy, Metal Working, Inorganic Chemistry, Catalysts, Electrophotography, Photolithography
2150/2160 Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
2180 Organic Chemistry, Polymers, Compositions
2190 Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus

Patents examined here cover:

Art Unit Technical & Scientific Domains
2410/2460/2470 Multiplex, VoIP
2420 Cable and Television
2430/2490 Cryptography and Security
2440/2450 Computer Networks
2480 Recording and Compression

Patents examined here cover:

Art Unit Technical & Scientific Domains
2610 Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory
2620 Selective Visual Display Systems
2630 Digital and Optical Communications
2640 Telecommunications: Analog Radio Telephone; Satellite and Power Control; Transceivers, Measuring and Testing; Bluetooth; Receivers and Transmitters; Equipment Details
2650 Videophones and Telephonic Communications; Audio Signals; Digital Audio Data Processing; Linguistics, Speech Processing and Audio Compression
2660 Digital Cameras; Image Analysis; Applications; pattern Recognition; Color and Compression; Enhancement and Transformation
2670 Facsimile; Printer; Color; halftone; Scanner; Computer Graphic Processing; 3-D Animation; Display Color; Attributes; Object Processing; Hardware and Memory
2680 Telemetry and Code Generation; Vehicles and System Alarms; Selective Communication; Dynamic Storage Systems; Mechanical parts of Disk Drives; Signal Processing and Control Processing in Disk Drives
2690 Selective Visual Display Systems

More broadly TC 2800 Art Units cover Semiconductors/Memory, Circuits/Measuring and Testing, Optics/Photocopying, Printing/Measuring and Testing.

Patents examined here cover:

Art Unit Technical & Scientific Domains
2810/2820/2890 Semiconductors/Memory
2830/2840 Electrical Circuits and Systems
2850/2860 Printing/Measuring and Testing
2870/2880 Optics

About Design Patents

The design FOR an article. Not to the design OF an article.

Patents examined here cover Design patents cover the appearance of an article. The design for an article consists of the visual characteristics embodied in or applied to an article. Since a design is manifested in appearance, the subject matter of a design patent application may relate to the configuration or shape of an article, to the surface ornamentation applied to an article, to the combination of configuration and surface ornamentation.

Design is inseparable from the article to which it is applied and cannot exist alone merely as a scheme of surface ornamentation. It must be a definite, preconceived thing, capable of reproduction and not merely the chance result of a method.

Design patent numbers begin with a "D" followed by a six-digit number. The first Design Patent was issued in 1843. The term of a design patent is 15 years measured from the date of grant if the design application was filed on or after May 13, 2015 (or 14 years if filed before May 13, 2015).

Patents examined here cover:

Art Unit Technical & Scientific Domains
3610 Surface Transportation
3620 Business Methods — Incentive Programs, Coupons; Operations Research; Electronic Shopping; Health Care; Point of Sale, Inventory, Accounting; Cost/Price, Reservations, Shipping and Transportation; Business Processing
3630 Static Structures, Supports and Furniture
3640 Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
3650 Material and Article Handling
3660 Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
3670 Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
3680 Business Methods — Incentive Programs, Coupons; Electronic Shopping; Business Cryptography, Voting; Health Care; Point of Sale, Inventory, Accounting; Business Processing, Electronic Negotiation
3690 Business Methods — Finance/Banking/ Insurance

Patents examined here cover:

Art Unit Technical & Scientific Domains
3710 Amusement and Education Devices
3720 Manufacturing Devices and Processes, Machine Tools and Hand Tools
3730 Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
3740 Thermal and Combustion Technology, Motive and Fluid Power Systems
3750 Fluid Handling and Dispensing
3760 Refrigeration, Vaporization, Ventilation, and Combustion
3770 Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
3780 Body Treatment, Kinestherapy, and Exercising

FedInvent Patents

Each week FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding from the US federal government. We assemble a weekly patent catalog and analyze the inventions, the inventors, and the entities who received the patents. We map the patents back to the agency that funded the R&D that led to the new invention. FedInvent uses the funding opportunity descriptions, the grants, and the contracts that define the research areas of interest ,and the R&D policies and priorities of that drove and are driving the funding to organize each week's patents.

ABOUT OUR DATA

The weekly patent catalog includes patents with government interest statements indicating federal funding; and patents where the assignee, the owner of the invention, is the federal government. This includes work on federal grants, work on federal contracts, innovation by Federal Research and Development Centers (FFRDCs) funded by Federal Departments, and University Affiliated Research Centers funded by DoD.

Not every inventor is a government contractor. There are many inventions conceived and patented by scientists and engineers working for the federal government or serving in the military.

THE NUMBERS MAY NOT MATCH THE NUMBER OF PATENTS WE ANALYZE EACH WEEK

The numbers in the tables presented on this page will not add up to the number of patents granted each week because patents are counted by each agency that funded the creation of the invention. Patents and funding have a many-to-many relationship. One patent may have more than one funding grant or contract associated with it. A grant or contract may lead to more than one patent. More than one agency may have funded the inventors or the contract. More than one university or business may have worked together on an invention. When we report the numbers here, we associate a patent with all of the entities and funding that are reflected on the patent and report them to you. This approach presents a more complete picture of what's going on in the federal innovation ecosphere. Put another way, the numbers in the tables presented on this page may not always add up to the number of patents each week because patents are counted by each agency that funded the creation of the invention.

Subscribe to The FedInvent™ Newsletter

 The latest from FedInvent delivered right to your inbox twice a week.